由于较低的进入部位并发症发生率和提高的患者满意度,桡动脉(RA)进入已越来越多地用于冠状动脉手术。然而,可用于周围血管介入(PVI)的RA入路的数据有限.我们对2020年2月至2022年9月在单一机构通过RA接受PVI的143例患者进行了回顾性审查。从前瞻性维护的机构数据库中确定了基线特征和后续数据。在491个PVI中,156例(31.8%)通过RA进行。介入的解剖位置为股骨(44.8%),髂关节(31.1%),pop(9.6%)腓骨(2.7%),胫骨(9.9%),锁骨下动脉(1.9%)。通过正确的RA获得了程序访问(92.9%),左RA(4.5%),或右尺动脉(2.6%)使用6法国R2P目的地细长鞘在85厘米,105厘米,和119厘米的长度。动脉粥样硬化切除术的使用率为34.7%。平均造影剂体积为105.5mL,平均透视时间为18.5分钟。由于动脉痉挛和不可交叉病变,3例(1.9%)发生了股动脉通路的转换。2例(1.3%)同时使用踏板。围手术期并发症发生率为3.84%,其中入路血肿最常见(3.2%);没有人需要输血,手术干预,或额外住院。住院脑卒中1例(0.64%)。30天的死亡率,6个月,1年期为1.4%,2.8%,和4.2%,分别。总之,RA接入对于不同的PVI是可行的,未来的研究需要评估与股动脉入路相比的安全性和益处.
Radial artery (RA) access has been increasingly utilized for coronary procedures because of lower rates of access-site complications and improved patient satisfaction. However, limited data are available for RA access for peripheral vascular intervention (PVI). We performed a retrospective review of 143 patients who underwent PVI through RA access from February 2020 to September 2022 at a single institution. Baseline characteristics and follow-up data were ascertained from a prospectively maintained institutional database. Of 491 PVI, 156 (31.8%) were performed through the RA. Anatomical locations for intervention were the femoral (44.8%), iliac (31.1%), popliteal (9.6%) peroneal (2.7%), tibial (9.9%), and subclavian (1.9%) arteries. Procedural access was obtained through the right RA (92.9%), left RA (4.5%), or right ulnar artery (2.6%) using the 6 French R2P Destination Slender sheath in 85, 105, and 119 cm lengths. Atherectomy was used in 34.7%. Mean contrast volume was 105.5 ml and the average fluoroscopy time was 18.5 minutes. Conversion to femoral access occurred in 3 cases (1.9%) because of arterial spasm and noncrossable lesions. Concomitant pedal access occurred in 2 cases (1.3%). Periprocedural complication rate was 3.84%, of which access-site hematoma was most common (3.2%); none required blood transfusion, surgical intervention, or additional hospital stay. There was 1 case (0.64%) of in-hospital stroke. The mortality rate at 30-day, 6-month, and 1-year was 1.4%, 2.8%, and 4.2%, respectively. In conclusion, RA access is feasible for diverse PVI, and future studies are needed to assess safety and benefit compared with femoral artery access.